我们的无创通气面罩产品组合 - 为您的病人提供舒适性

新闻

日期: 07.10.2022

Hamilton Medical 哈美顿医疗公司与 Pulmodyne 联手，为您的病人提供全面的连接界面。

在治疗过程中交替使用面罩类型

长时间佩戴无创通气面罩可能导致压疮的发生 (Grieco DL, Maggiore SM, Roca O, et al.Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.Intensive Care Med.2021;47(8):851-866. doi:10.1007/s00134-021-06459-21)。防止这种情况的一种方法是在治疗期间交替使用面具类型 - 这就是为什么我们提供各种不同尺寸和配置的面罩。我们的产品组合包括不同配置和尺寸的儿童和成人面罩，有排气孔或无排气孔，以及带或不带防窒息阀门。它们都是为了提高病人在呼吸窘迫情况下的舒适度和顺应性而设计的。

它们的最佳贴合可舒缓压迫点。
双唇垫的设计提供了有效的密封。
前额垫将面罩保持在适当位置，不会影响佩戴舒适度。

您可以选择鼻部、口鼻或全周长的面罩配置，以确保最适合每个病人的情况。如果您想知道各种配置之间的差异，这里有一个快速概览：

鼻面罩（BiTrac 无创通气）

鼻面罩（仅在美国有售）是对口鼻面罩的补充。它在鼻子上的位置使病人可以自由地进食和说话，从而提高他们的生活质量。鼻面罩还能减少发生压疮风险的皮肤数量。然而，这些面罩的功效取决于病人是否闭口。

口鼻面罩（BiTrac 无创通气）

口鼻面罩是无创通气治疗的标准。口鼻面罩适用于有高呼吸需求的病人或需要无创通气（NIV）进行呼吸支持的自主呼吸的病人。面罩的形状允许病人用嘴呼吸，因此二氧化碳的排出更顺畅，因为鼻腔阻力最小。

全周长面罩 (BiTrac MaxShield)

全周长面罩避免了对鼻子的直接压力，而是将其分散在一个更大的表面区域。全周长面罩还可以减少病人的幽闭恐惧感。通过对脸部周围的密封，面罩对鼻梁难题或其他面部变形和异常的情况提供了一个很好的解决方案。

有关详细的订购信息，请联系您当地的 Hamilton Medical 哈美顿医疗公司代表或访问我们的 Hamilton Medical 哈美顿医疗公司电子产品目录。

请点击下面的链接来探索我们的全系列面罩指南。

无创通气面罩

脚注

A. 仅在美国提供

参考文献

1. Grieco DL, Maggiore SM, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866. doi:10.1007/s00134-021-06459-2

Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.

Grieco DL, Maggiore SM, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866. doi:10.1007/s00134-021-06459-2

Link to article

The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory distress syndrome is debated. The oxygenation improvement coupled with lung and diaphragm protection produced by non-invasive support may help to avoid endotracheal intubation, which prevents the complications of sedation and invasive mechanical ventilation. However, spontaneous breathing in patients with lung injury carries the risk that vigorous inspiratory effort, combined or not with mechanical increases in inspiratory airway pressure, produces high transpulmonary pressure swings and local lung overstretch. This ultimately results in additional lung damage (patient self-inflicted lung injury), so that patients intubated after a trial of noninvasive support are burdened by increased mortality. Reducing inspiratory effort by high-flow nasal oxygen or delivery of sustained positive end-expiratory pressure through the helmet interface may reduce these risks. In this physiology-to-bedside review, we provide an updated overview about the role of noninvasive respiratory support strategies as early treatment of hypoxemic respiratory failure in the intensive care unit. Noninvasive strategies appear safe and effective in mild-to-moderate hypoxemia (PaO2/FiO2 > 150 mmHg), while they can yield delayed intubation with increased mortality in a significant proportion of moderate-to-severe (PaO2/FiO2 ≤ 150 mmHg) cases. High-flow nasal oxygen and helmet noninvasive ventilation represent the most promising techniques for first-line treatment of severe patients. However, no conclusive evidence allows to recommend a single approach over the others in case of moderate-to-severe hypoxemia. During any treatment, strict physiological monitoring remains of paramount importance to promptly detect the need for endotracheal intubation and not delay protective ventilation.